N-benzyl-4-chloro-N-cyclohexylbenzaMide
- Product Name
- N-benzyl-4-chloro-N-cyclohexylbenzaMide
- CAS No.
- 945714-67-0
- Chemical Name
- N-benzyl-4-chloro-N-cyclohexylbenzaMide
- Synonyms
- CS-2304;FPS-ZM1;FPS-ZM1, 10 mM in DMSO;FPS-ZM1, RAGE receptor antagonist;N-benzyl-4-chloro-N-cyclohexylbenzaMide;4-Chloro-N-cyclohexyl-N-(phenylmethyl)benzamide;Benzamide, 4-chloro-N-cyclohexyl-N-(phenylmethyl)-
- CBNumber
- CB52660739
- Molecular Formula
- C20H22ClNO
- Formula Weight
- 327.85
- MOL File
- 945714-67-0.mol
N-benzyl-4-chloro-N-cyclohexylbenzaMide Property
- Boiling point:
- 497.6±38.0 °C(Predicted)
- Density
- 1.18±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- Soluble in DMSO (up to 35 mg/ml) or in Ethanol (up to 20 mg/ml)
- pka
- -1.54±0.20(Predicted)
- form
- solid
- color
- Off-white
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
- InChI
- 1S/C20H22ClNO/c21-18-13-11-17(12-14-18)20(23)22(19-9-5-2-6-10-19)15-16-7-3-1-4-8-16/h1,3-4,7-8,11-14,19H,2,5-6,9-10,15H2
- InChIKey
- XDFKWGIBQMHSOH-UHFFFAOYSA-N
- SMILES
- O=C(C1=CC=C(Cl)C=C1)N(CC2=CC=CC=C2)C3CCCCC3
Safety
- WGK Germany
- WGK 3
- Storage Class
- 11 - Combustible Solids
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P271Use only outdoors or in a well-ventilated area.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P321Specific treatment (see … on this label).
P330Rinse mouth.
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P337+P313IF eye irritation persists: Get medical advice/attention.
P403+P233Store in a well-ventilated place. Keep container tightly closed.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 553030
- Product name
- RAGE Antagonist, FPS-ZM1
- Purity
- RAGE Antagonist, FPS-ZM1, is a blood-brain-barrier permeant blocker of RAGE V domain-mediated ligand binding (K<sub>i</sub> = 25, 148, & 230 nM, respectively, against Aβ40, HMGB1 & S100B
- Packaging
- 25 mg
- Price
- $229
- Updated
- 2026/04/30
- Product number
- 11909
- Product name
- FPS-ZM1
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $33
- Updated
- 2026/04/30
- Product number
- 11909
- Product name
- FPS-ZM1
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $60
- Updated
- 2026/04/30
- Product number
- 11909
- Product name
- FPS-ZM1
- Purity
- ≥98%
- Packaging
- 25mg
- Price
- $116
- Updated
- 2026/04/30
- Product number
- 11909
- Product name
- FPS-ZM1
- Purity
- ≥98%
- Packaging
- 50mg
- Price
- $163
- Updated
- 2026/04/30
N-benzyl-4-chloro-N-cyclohexylbenzaMide Chemical Properties,Usage,Production
Description
FPS-ZM1 (945714-67-0) is a high-affinity RAGE (Receptor for Advanced Glycation End products) receptor antagonist (IC50= 0.6 μM). It lowers levels of Aβ via binding to the V domain of RAGE and can block multiple mechanisms of Aβ40- and Aβ42-induced cellular stress in RAGE-expressing brain endothelium, neurons and microgliain vitroandin vivo.1,2 Can cross the BBB. In a rat model of intracerebral hemorrhage, FPS-ZM1 was able to attenuate blood-brain barrier and white matter fiber damage.3FPS-ZM1 antagonism of RAGE was able to ameliorate inflammatory damage after acute intracerebral hemorrhage via downstream blockade of high mobility box-1(HMGB1) signaling.4 FPS-ZM1 has also been shown to impair breast cancer cell invasion and metastasis.5
Uses
FPS-ZM1 is a blood-brain-barrier permeant blocker of RAGE V domain-mediated ligand binding (Ki= 25, 148, & 230 nM, respectively, against Aβ40, HMGB1 & S100B, binding to sRAGE).
Synthesis
4383-25-9
122-01-0
945714-67-0
General methodology: to synthesize N-benzyl-4-chloro-N-cyclohexylbenzamide (Compound 1), cyclohexylamine (0.5 M in methanol) was first mixed with benzaldehyde (0.5 M in methanol) and stirred for 3 hrs at 64 °C. Upon completion of the reaction, the mixture was cooled to room temperature, followed by the addition of sodium cyanoborohydride (0.5 M ethanol solution) in two additions, each followed by stirring at room temperature for 30 minutes. Next, the reaction mixture was reheated to 64 °C with continuous stirring for 6 hours. At the end of the reaction, the reaction was quenched with water and extracted three times with dichloromethane. The organic phases were combined, dried with magnesium sulfate and subsequently concentrated under vacuum. The resulting secondary amine was dissolved in anhydrous dichloromethane and mixed with p-chlorobenzoyl chloride. Assuming 100% yield of secondary amine, dimethylaminopyridine (0.1 eq.) dissolved in anhydrous dichloromethane was added to the secondary amine solution, followed by diisopropylethylamine (1.1 eq.). The reaction mixture was purged with nitrogen and sealed and stirred at room temperature overnight. Upon completion of the reaction, the mixture was concentrated under vacuum to an oil, redissolved and purified by reverse phase preparative HPLC (isocratic elution conditions: 75% acetonitrile, 25% water). After purification, the purity of the compounds was determined using reversed-phase analytical HPLC to ensure an average purity greater than 95% (see Supplementary Table 1). Compound 1 was characterized by the following data: IR (CDCl3 film): 2935, 2858, 2246, 1624, 1495, 1418, 1091, 908, 838, 734 cm-1 ; 1H NMR (400 MHz, CDCl3) δ 7.52 (4H), 7.36 (4H), 7.20 (2H), 4.55 (1H) , 3.65 (1H), 1.80 (4H), 1.47 (4H), 1.06 (2H); 13C NMR (75 MHz, CDCl3) δ 171.2, 142.5, 139.0, 135.2, 128.7, 128.4, 127.7, 126.8, 77.17, 59.4, 59.4, 44.6, 32.0 , 30.8, 25.7, 25.1, 25.1, 9.29; HRMS m/z calculated value (M + H)+: 328.1390, measured value: 328.1477.
in vitro
fps-zm1 was identified as a high-affinity inhibitor of the receptor for advanced glycation end products. fps-zm1 could block the binding of amyloid β (aβ) protein to rage and inhibit aβ40- and aβ42-induced cellular stress in rage-expressing cells [1].
in vivo
animal study found that fps-zm1 was nontoxic to mice and readily crossed the blood-brain barrier (bbb). in aged appsw/0 mice overexpressing human aβ-precursor protein, fps-zm1 could inhibit rage-mediated influx of circulating aβ40 and aβ42 into the brain. fps-zm1 bound exclusively to rage in brain, which inhibited β-secretase activity and aβ production and suppressed microglia activation and the neuroinflammatory response. moreover, the blockade of rage actions at the bbb and in the brain could reduce aβ40 and aβ42 levels in brain in aged appsw/0 mice [1].
storage
Store at -20°C
References
[1] RASHID DEANE. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.[J]. The Journal of clinical investigation, 2012: 1377-1392. DOI:10.1172/jci58642
[2] YAN HONG. Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus[J]. Neurochemical Research, 2016, 41 5: 1192-1199. DOI:10.1007/s11064-015-1814-8
[3] FAN YANG. Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage.[J]. Stroke, 2015, 46 5: 1328-1336. DOI:10.1161/strokeaha.114.008336
[4] DAN LI . Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage[J]. Neuroscience Letters, 2015, 609: Pages 109-119. DOI:10.1016/j.neulet.2015.10.035
[5] T KWAK. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis[J]. Oncogene, 2016, 36 11: 1559-1572. DOI:10.1038/onc.2016.324
N-benzyl-4-chloro-N-cyclohexylbenzaMide Preparation Products And Raw materials
Raw materials
Preparation Products
N-benzyl-4-chloro-N-cyclohexylbenzaMide Suppliers
- Tel
- Fax
- 86-21-57758967
- sales@boylechem.com
- Country
- China
- ProdList
- 2922
- Advantage
- 55
- Tel
- 025-66113011 17714375163
- Fax
- (1)02557626880
- cfzhang@aikonchem.com
- Country
- China
- ProdList
- 19906
- Advantage
- 55
- Tel
- 02136680027 15800370750
- 1706640024@qq.com
- Country
- China
- ProdList
- 485
- Advantage
- 56
- Tel
- 021-58950125
- Fax
- (86) 21-58955996
- info@chemexpress.com
- Country
- China
- ProdList
- 7552
- Advantage
- 61
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- 400-400-164-7117 18317119277
- Fax
- +86-21-61629029
- product02@bidepharm.com
- Country
- China
- ProdList
- 39999
- Advantage
- 60
- Tel
- 13120367189
- Fax
- 021-50315529
- mychess007@163.com
- Country
- China
- ProdList
- 1994
- Advantage
- 55
- Tel
- 025-57018978 18251899859
- Fax
- 025-57018008
- sales@chalf-pharm.com
- Country
- China
- ProdList
- 5882
- Advantage
- 50
- Tel
- 025-58849295 18951903616;
- Fax
- 025-68650336
- info@adooq.cn
- Country
- China
- ProdList
- 2990
- Advantage
- 60
- Tel
- 13621943973
- Fax
- -
- sales@shjiyipharmatech.com
- Country
- China
- ProdList
- 1166
- Advantage
- 55
View Lastest Price from N-benzyl-4-chloro-N-cyclohexylbenzaMide manufacturers
- Product
- N-benzyl-4-chloro-N-cyclohexylbenzaMide 945714-67-0
- Price
- US $2.00/KG
- Min. Order
- 1g
- Purity
- 98%min
- Supply Ability
- ask
- Release date
- 2020-01-08
- Product
- N-benzyl-4-chloro-N-cyclohexylbenzaMide 945714-67-0
- Price
- US $1.00/ASSAYS
- Min. Order
- 1ASSAYS
- Purity
- 95%~99%
- Supply Ability
- per week:100kg
- Release date
- 2019-09-05